-
-
Call more information
660-596-2224 -
I thought this was interesting so I wanted to share with our readers. Author: Jaime Rosenberg AJMC The FDA has approved esketamine for adult patients with treatment-resistant depression. The treatment has demonstrated improvement in depression symptoms, as well as sustained improvement in symptoms. After much anticipation, the FDA has given the nod to the first new […]
Read MoreAnesthesiology News The Frost Series #347 Written by: Rita Agarwal, MD, FAAP; and Echo Rowe, MD, FAAP Case Presentation A 10-year-old boy was scheduled for a CT-guided biopsy of a thoracic mass. The otherwise healthy child presented with a 3- to 4-month history of back pain. MRI revealed a right posterior paraspinal mass anterior to […]
Read MoreAuthors: Pearse R et al BMJ Case Reports 12 (2), (Feb 2019) Although cocaine induced myopathy and myotoxicity are described in the literature, we report a rare case of cocaine induced paraspinal myositis presenting with acute sciatic symptoms. A 35-year-old man presented with acute left-sided sciatica and was discharged from the emergency department (ED). He […]
Read MoreAuthor: Thomas Rosenthal Anesthesiology News Health care–associated infections, which the CDC states take tens of thousands of lives and cost the U.S. healthcare system billions of dollars each year, decreased from one in every 20 to one in every 25 hospitalized patients from 2013 to 2018, according to the federal agency. “The tremendous reductions in […]
Read MoreAuthor: Michael Vlessides Anesthesiology News A screening tool designed to identify surgical patients at high risk for obstructive sleep apnea (OSA) bolsters clinical decision making and reduces both respiratory complications and hospital utilization rates. “In 2006, the Joint Commission recommended that hospitals establish screening tools for OSA,” said Katharina S. Platzbecker, MD, a research fellow […]
Read More